Number of patients
|
1978
|
632 (32%)
|
190 (9.6%)
|
157 (7.9%)
|
Women (%)
|
39
|
40
|
27
|
23
|
ICU length-of-stay (days)
|
1.7 (0.8–3.8)
|
2.5 (1.1–5.5)
|
2.4 (0.97–4.3)
|
1.8 (0.93–4.1)
|
ICU mortality (%)
|
11
|
14
|
34
|
4.5
|
30-day mortality (%)
|
22
|
28
|
54
|
12
|
SAPS-3 score
|
59 (47–71)
|
66 (57–77)
|
76 (66–87)
|
48 (39–59)
|
Day-one SOFA score
|
7 (4–10)
|
8 (6–11)
|
10 (8–13)
|
5 (2–7)
|
Day-two SOFA score (n = 995)
|
8 (5–10)
|
8 (6–11)
|
10 (8–12)
|
6 (4–9)
|
CRRT during ICU stay (%)
|
9.2
|
15
|
7.4
|
0.6
|
Box I
| | | | |
Age (years)
|
66 (54–74)
|
69 (61–76)
|
68 (60–76)
|
55 (33–70)
|
Comorbidities
| | | | |
- Cancer therapy (%)
|
4.6
|
6.3
|
4.2
|
0.6
|
- Chronic heart failure (%)
|
5.5
|
7.0
|
10
|
1.3
|
- Haematological cancer (%)
|
2.6
|
5.2
|
1.0
|
0
|
- Liver cirrhosis (%)
|
1.1
|
1.6
|
0
|
0
|
- Cancer (%)
|
10.4
|
10.4
|
7.9
|
1.3
|
Vasoactive drugs before ICU (%)
|
44
|
47
|
64
|
21
|
Box II
| | | | |
Surgical status at ICU admission
| | | | |
- No surgery (%)
|
74
|
85
|
94
|
83
|
Box III
| | | | |
GCS
|
13 (10–15)
|
13 (10–15)
|
3 (3–8)
|
10 (6–15)
|
Total bilirubin (μmol/L)
|
9 (6–15)
|
10 (7–19)
|
8 (5–12)
|
8 (5–12)
|
Max. temperature (∘C)
|
37.0 (36.3–37.6)
|
37.3 (36.5–38.1)
|
36.0 (35.5–36.8)
|
37.0 (36.0–37.5)
|
Max. creatinine (μmol/L)
|
93 (70–145)
|
119 (79–205)
|
112 (87–149)
|
87 (74–111)
|
Max. heart rate (bpm)
|
100 (80–118)
|
107 (90–122)
|
98 (80–115)
|
90 (80–110)
|
Max. leukocyte count (×109/L)
|
13 (8.8–18)
|
13 (8.4–19)
|
16 (12–21)
|
14 (11–19)
|
Min. pH
|
7.34 (7.24–7.41)
|
7.32 (7.20–7.40)
|
7.19 (7.04–7.3)
|
7.34 (7.29–7.40)
|
Min. platelet count (×109/L)
|
221 (161–286)
|
218 (147–304)
|
222 (165–270)
|
212 (171–261)
|
Min. systolic blood pressure (mmHg)
|
100 (80–120)
|
91 (75–115)
|
85 (68–109)
|
104 (90–130)
|
Oxygenation
| | | | |
- Respiratory support (%)
|
58
|
59
|
86
|
53
|
- FiO2 (%)
|
50 (40–70)
|
60 (40–80)
|
60 (50–80)
|
45 (40–57)
|
- PaO2 (kPa)
|
13 (9.8–18)
|
11 (9.0–15)
|
13 (11–22)
|
16 (11–24)
|
Other
| | | | |
cDPP3 (ng/mL)
|
19 (13–33)
|
19 (13–31)
|
44 (28–69)
|
22 (14–38)
|